Previously, umbilical cord blood stem cells were good for children but now this is safe and effective for adults with blood cancers.
They grew more umbilical cord blood stem cells outside the body then transplanted it into an adult blood cancer patients. They were able to restore a normal of blood cells.
Immune therapy company Gamida Cell produces this umbilical cord blood stem cell treatment known as NiCord, and after more successful trials plan to seek approval from the FDA.
They shorten the time that adult blood cancer patients have a compromised immune system down to 11.5 days.
94 percent of adult patients with blood cancers who received the umbilical cord blood treatment ended up with successful graft procedures within six weeks.